BioCentury
ARTICLE | Company News

Asklepion Pharmaceuticals, Retrophin deal

July 25, 2016 7:00 AM UTC

Retrophin acquired a liquid formulation of ursodeoxycholic acid (UDCA) from Asklepion. Solid formulations of UDCA, a naturally occurring bile acid, are available as generics to treat primary biliary c...